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Abstract 
A combination of Paracetamol and Tramadol is used in mild to 
severe pain management. In a private Hospital Semarang, this 
combination is included in fast-moving drugs that it is frequently 
compounded and prepared in advance. The study aims to 
determine Beyond Use Date (BUD) in compounding capsules 
combination between Paracetamol and Tramadol samples. Beyond 
Use Date is a time limit indicating that a medicine beyond the 
expiration date must not be used and determined based on the 
results of stability testing. Samples were stored for 14 days in a 
tightly closed container far from direct sunlight in room 
temperature without AC (280C) and without silica gel, room 
temperature with AC (250C) without silica gel, and room 
temperature with AC (250C) with silica gel. Furthermore, samples 
underwent physical and chemical stability testing. Physical stability 
testing was conducted using organoleptic testing by observing 
direct changes from the powder color in capsules, capsules form, 
and scent on the samples. Meanwhile, chemical stability testing 
was conducted by determining the content of active ingredient 
from the samples using reversed-phase HPLC method and C18 as 
the stationary phase, methanol and aquabidest (40:60) as the 
mobile phase, wavelength 271 nm, flow rate 0.6 mL/min and 
injection volume 10 μL. The result shows that samples were 
physically stable for being able to retain the original physical 
properties showed by consistent powder color and capsules form, 
and there was no available scent. However, the chemical stability 
testing method was unable to separate and quantify the content of 
Paracetamol, Tramadol, and formed degradation products. It can 
be concluded that Beyond Use Date based on organoleptic and 
chemical stability testing for 14 days of compounding capsules 
combination between Paracetamol and Tramadol could not be 
determined. Nevertheless, this study showed favorable storage 
conditions in a tightly closed container far from direct sunlight in 
Room Temperature with AC (250C) with Silica Gel. 
 




















25 Feb 2020 
7 Apr 2020 





Type of article: 
Research 
 
                                                          
* Corresponding author, e-mail: mr_gani@usd.ac.id 
Shirley Candra Kurniawan, Michael Raharja Gani, Sri Hartati Yuliani | Stability Testing of Compounding Capsule 





Compounding is the process of 
combining, admixing, diluting, pooling, 
reconstituting other than as provided in 
the manufacturer’s labeling, or otherwise 
altering a drug or bulk drug substance to 
create a non-sterile medication.1 
Limitations of extemporaneous 
compounding practice in drug formulas 
are not available on the market, 
limitations of the patient’s condition in 
consuming the dosage forms, limited 
supply of drug preparations, patient 
compliance, and medical costs in the 
market.2 Stability is the extent to which a 
product or preparation retains physical 
and chemical properties and 
characteristics within specified limits 
throughout its expiration or Beyond Use 
Date.1 The stability of a pharmaceutical 
product may be defined as the capability 
of a particular formulation in a specific 
container/closure system to remain within 
its physical, chemical, microbiological, 
toxicological, protective, and 
informational specifications.3 Stability 
studies are carried out to establish a 
Beyond Use Date for the compounded 
preparation. The Beyond Use Date 
indicates the days after the compounded 
formula is prepared in which the product 
is no longer safe to be used.1 
 
High-Performance Liquid 
Chromatography (HPLC) is one of the 
separation methods in a column 
containing a stationary phase that will be 
flowed by the mobile step.4 Reversed-
Phase will elute samples with higher 
polarity earlier as the characteristic of the 
mobile phase is more polar than the 
stationary phase.5 HPLC method is used 
since the chromatography technique can 
separate a mixture of compounds and is 
used to identify, quantify and purify the 
individual components of the mixture 
with better, faster, and more efficient 
compound separation results.4,6 
Reversed-phase of HPLC with a UV 
detector provides the best available 
reliability, analysis time, repeatability, 
sensitivity, and capable of monitoring 
several wavelengths concurrently.7 
 
Combination of Paracetamol and 
Tramadol works synergistically with 
different mechanisms of action and used 
as a second-line medication for the 
treatment of moderate to severe pain 
management.8 In a private Hospital, 
Semarang, this combination is included in 
fast-moving drugs. Yet, the prices are 
quite high on the market, that it is 
frequently compounded to lower the cost 
of the medication. Real-time stability 
testing was carried out to assign Beyond 
Use Date; thus, it can be used as a 
reference in storing and maintaining 
compounding capsules combination 




The materials were working standards of 
the pharmaceutical-grade of Paracetamol 
(batch no. WS-QC-400395378) and 
Tramadol (batch no. 100209203). It was 
used without further purification and 
certified to contain 99.3 % of Paracetamol 
and 99.2 % of Tramadol on a dry weight 
basis. The materials were such as 
paracetamol tablet 500 mg 
(Promedrahardjo Pharmaceutical 
Industries, batch no. 00818L0110) and 
Tramadol capsules 50 mg (Otto 
Pharmaceutical Industries, batch no. 8J 
0935). Methanol gradient grade for liquid 
chromatography E.Merck®, Aquabidest 
was obtained from Water Purification 
System Easy Pure II RF, hard capsules 
shell, and silica gel. 
 




Instrumentation and chromatographic 
conditions used was the HPLC system 
(Shimadzu®, LC-2010HT), consisting of a 
Pump with a dual serial plunger, micro-
volume (10 μL on the primary side, 5 μL 
on secondary along with autosampler 
injector programmed at 10 µl capacity per 
injection, was used. The detector 
consisting of UV. LC separations was 
performed on a Phenomenex C18 column 
(250×4.6 mm i.d., 5 μm particle size). The 
mobile phase consisted of 40: 60 (v/v); 
methanol: aquabidest. The flow rate was 
set to 0.6 mL/min, and UV detection was 
carried out at 271 nm. Other materials 
and tools were such as ultrasonication 
Retsch® T460, analytical scales Ohaus® 
PAJ1003 (max 120g, min 0.001g), 
micropipette Socorex® (0.1-2μL; 10-
100μL; and 100-1000μL), millipore filter 
(0.45μm), solvent membrane filter 
Whatman® (0.45μm), microtube 1mL, 
injection spuit 5mL, Pyrex glassware, 
tightly closed container, mortar, and 
pestle.  
 
There were two kinds of samples made, 
which were compounding capsules 
combination between Paracetamol and 
Tramadol and compounding capsules of 
Tramadol. The first samples were 
prepared by finely powdered a tablet of 
Paracetamol and a pill of Tramadol 
separately. The accurate weight of the 
powder, which was 25 mg of Paracetamol 
and 10 mg of Tramadol, was weighed and 
mixed before being inserted into an 
empty capsule shell. The second samples 
were made by 10 mg of a finely powdered 
capsule of Tramadol and were inserted 
into an empty capsule shell. Furthermore, 
samples were stored for 14 days in a 
tightly closed container far from direct 
sunlight with three different storage 
conditions such as room temperature 
without AC (280C) and without silica gel, 
room temperature with AC (250C) without 
silica gel, and room temperature with AC 
(250C) and with silica gel. The third 
condition conformed to private hospital 
Semarang conditions. Physical and 
chemical stability testing was conducted 
to the samples on Day - 0, 1, 3, 7, 10,14. 
 
Organoleptic testing 
The characteristic of the physical stability 
of the samples was determined by 
observing direct changes from the 
powder color in capsules, capsules form, 
and scent on the samples. The parameter 
used was the result on Day - 0 as the 
sample was freshly made and expected to 
have higher stability than the sample with 
a longer storage period.  
 
Chemical stability testing 
The chemical analysis performed in this 
study was conducted by determining the 
content of active ingredient from the 
samples using reversed-phase HPLC 
method and using Phenomenex C18 (5 
µm) as the stationary phase, methanol 
and aquabidest (40:60) as the mobile 
phase, wavelength 271 nm, flow rate 0.6 
mL/min and injection volume 10 μL [9].  
 
Standard solutions and calibration   
A stock standard solution containing 
Paracetamol (2500 µg/mL) and Tramadol 
(1000 µg/mL) was prepared by dissolving 
25 mg of Paracetamol and 10 mg of 
Tramadol in 10 mL volumetric flask with 
methanol. It was further diluted to obtain 
working standard solutions in a 
concentration range of 0.05 – 2.45 µg/mL 
(i.e. 0.05; 0.45 ; 0.85 ; 1.25 ; 1.65 ; 2.05 ; 
and 2.45 μg/mL) for Paracetamol and 1 
μg/mL for Tramadol. This solution was 
filtered through a 0.45 μm millipore then 
transferred to HPLC vials and sonicated 
for 10 min. A constant volume of 10 µL 
injections was made for each 
concentration of three replications and 
chromatography under the above-
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mentioned conditions. The peak areas 
were plotted against the corresponding 
concentrations to obtain the calibration 
graphs. Linear calibration curves were 




Samples that had been stored were taken 
and transferred into 10 mL volumetric 
flask and diluted to 10 mL with mobile 
phase methanol and aquabidest (40:60). 
0.286 μL of compounding capsules 
combination between Paracetamol and 
Tramadol was transferred to 1 ml 
microtube, and 999.714 μL of the mobile 
phase was added. 1 μL of compounding 
capsules of Tramadol was then 
transferred to 1 mL microtube, and 999 
μL of the mobile phase was added. The 
concentration achieved after the above-
mentioned dilution was 1 μg/mL. This 
solution was filtered through a 0.45 μm 
millipore, then transferred to HPLC vials 
and sonicated for 10 min. A constant 10 
µL volume of sample solution was 
injected under the above-mentioned 
conditions. The peak areas were 
measured at 271 nm, and their contents in 
the samples were determined using a 
multilevel calibration curve developed on 
the same HPLC system under the same 
conditions using the linear regression 
equation. 
 
RESULTS AND DISCUSSION 
 
Organoleptic testing 
This test is carried out to identify the 
physical stability of the compounded 
preparation and to establish a Beyond 
Use Date. Table 1 and Figure 1 show that 
within 14 days of storage, compounding 
capsules combination between 
Paracetamol and Tramadol, 
compounding tablet of Paracetamol, and 
compounding capsules of Tramadol 
remained consistent in powder color and 
capsules form, and there is no available 
scent on the samples. It indicates that the 
compounded preparation is physically 
stable for being able to retain the original 
physical properties.10  
Table 1. Organoleptic studies 
Sample storage 
time 
Room temp. without AC (280c) 
and silica gel 
Room temp. with AC (250c) and 
without silica gel 
Room temp. with AC (250c) and 
silica gel 
Day - 0 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Day -  1 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Day - 3 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Day - 7 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Day - 10 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Day - 14 TB    : white 
PC    : white 
CF    : rigid 
Scent  : -  
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
TB    : white 
PC    : white 
CF    : rigid 
Scent  : - 
Information: Powder color in tablets (TB), capsules (PC), capsules form (CF)  





Prior to Storage 
 
After Storage 
Figure 1. The physical appearance of the sample 
 
 
Figure 2. Chromatogram of Paracetamol 
standard 0,45 μg/mL 
 
Figure 3. Chromatogram of Tramadol 
standard 1 μg/mL 
 
Figure 4. Chromatogram of compounding 
capsules combination between Paracetamol 
and Tramadol 1 μg/mL 
 
Figure 5. Chromatogram of compounding 
capsules of Tramadol 1 μg/mL 
 
However, this testing has a high 
subjectivity; thus, chemical stability 
testing is required to determine the 
stability of compounded preparation. 
Chemical Stability Testing 
Chemical stability is the ability of each 
active ingredient to retain its chemical 
integrity and labeled potency within the 
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specified limits.10 This chemical stability 
testing is carried out to establish a 
Beyond Use Date. 
 
Linearity 
Linear relationships were observed by 
plotting Paracetamol concentration 
against obtained peak areas. Paracetamol 
showed linear response in the 
concentration of 0.05; 0.45; 0.85; 1.25; 
1.65; 2.05; and 2.45 μg/mL. The 
corresponding linear regression equation 
was y = 22746x + 9210.3 with correlation 
coefficient (r) of 0.9927 indicating the 
linear relationship between increased 
concentration and instrument response. 
 
The retention time for Paracetamol 
standard 0.45 μg/mL, Tramadol standard 
1 μg/mL, compounding capsules 
combination between Paracetamol and 
Tramadol 1 μg/mL, and compounding 
capsules of Tramadol 1 μg/mL was found 
to be 6.504; 6.502; 6.541; and 0 minutes 
respectively. Retention time is a measure 
of the time taken by solute to pass 
through a column to the detector. In this 
study, reversed-phase chromatography 
was used with the mobile phase, which 
was more polar than the stationary phase; 
thus, the more polar compounds would 
have earlier retention time. The retention 
time variation requirement was ≤0.05 
minutes.11 The time difference obtained 
from the time retention of Paracetamol 
standard and compounding capsules 
combination between Paracetamol and 
Tramadol was 0.037 minutes; therefore, 
Paracetamol was found in the 
compounded preparation samples. In 
Figure 5, the AUC and the time retention 
cannot be determined as, at 1 μg/mL, the 
Tramadol samples also contain 
excipients, which make the concentration 
measured lower than 1 μg/mL. 
 
Based on Figure 6, it can be concluded 
that Paracetamol is more stable at room 
temperature with AC (250C) and silica gel 
as, in the other two conditions, there is an 




Figure 6. Paracetamol content in three different storage conditions 
 




Decreased Paracetamol content 
There is a decreased Paracetamol content 
since the physical or chemical 
characteristics of the compounded 
preparation can change over time.1 
Humidity will be more controlled at room 
temperature with AC (250C) because AC 
will absorb humid air in the room. 
Humidity in room temperature without 
AC (280C) will vary based on the 
environmental humidity. Moreover, silica 
gel can help to slow down decreased 
Paracetamol content as the microporous 
structure in silica gel has the capacity to 
absorb the water vapor into those 
cavities. There is no chemical reaction 
taken place in the way silica gel adsorbs 
moisture. It happens due to the difference 
in water vapor gradient between the 
surrounding environment and the 
microcavities in silica gel. The moisture 
absorption is taken place until the cavities 
are saturated or until the water vapor 
pressure of the surrounding environment, 
and microcavities have gained an 
equilibrium, which is mostly around 12 
weeks.12 
  
Increased Paracetamol content 
There is increased Paracetamol content 
because, during storage, gelatin capsules 
can absorb or release moisture. When 
stored in a high relative humidity 
environment, hard gelatin capsules can 
absorb moisture and lose their rigid shape 
and become distorted. Whereas, in a 
different environment of extreme 
dryness, capsules may become too 
brittle.13 Paracetamol contains the amide 
group, which may be sensitive to 
hydrolysis degradation.14 Hydrolysis takes 
place in labile carbonyl function groups, 
which include amides, esters, arylamines, 
imides, imines alcohols, and 
carbamates.15  During the storage 
process, hydrolysis degradation of 
Paracetamol may occur and produce p-
aminophenol, which is stated to be a very 
toxic substance and has the ability to 
cause nephrotoxicity, teratogenicity, and 
methemoglobinemia.16 
  
Paracetamol degradation product can be 
measured in the HPLC system as it has a 
similar structure to Paracetamol and 
because the HPLC system for degradation 
product is not optimized. Mechanism of 
the Paracetamol oxidation pathway is 
favored by the hydroxylation of the 
benzene ring, leading to the formation of 
3-hydroxyacetaminophen and releasing 
acetamide as a reaction of byproduct. The 
breakdown of the bond between the 
amino group and the substituted 
methanol in the paracetamol molecule 
can lead to degradation of byproducts 
with substituted nitrogens, such as 4-
aminophenol and nitrophenol. The 
mineralization of paracetamol appears 
through ortho, meta, and para-
substituted oxidation pathways, leading 
to the formation of dihydroxy aromatic 
rings such as catechol, resorcinol, 
hydroquinone as well as trihydroxylated 
rings such as pyrogallol, phloroglucinol, 
and hydroxyhydroquinone.17  
 
Moreover, the time difference obtained 
from the time retention of Paracetamol 
standard (6.504) and Tramadol standard 
(6.502) is 0.002 minutes. Therefore, there 
is a possibility that Tramadol is also 
measured in the area of Paracetamol due 
to the slight difference in time retention, 
which is ≤0.05 minutes.12 
 
Beyond Use Date 
In the absence of a USP-NF compounded 
preparation of monograph or specific 
stability information for solid dosage 
forms (capsules, tablets, granules, 
powders), the maximum BUD packaged 
in tight, light-resistant containers in 
controlled room temperature (200-250 C) 
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is 180 days.1 In this study, Beyond Use 
Date based on organoleptic and chemical 
stability testing for 14 days of 
compounding capsules combination 
between Paracetamol and Tramadol is 
unable to be determined as the chemical 
stability testing method cannot separate 
and quantify the content of Paracetamol, 
Tramadol, and formed degradation 
product. Nevertheless, this study showed 
favorable storage conditions in a tightly 
closed container far from direct sunlight 





Beyond Use Date based on organoleptic 
and chemical stability testing for 14 days 
of compounding capsules combination 
between Paracetamol and Tramadol is 
unable to be determined. Nevertheless, 
this study showed favorable storage 
conditions in a tightly closed container far 
from direct sunlight in Room 
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